震え:臨床的枠組み,ネットワーク機能障害,治療法
Emmanuel Ortega-Robles1, Oscar Arias-Carrión1,2
1División de Neurociencias, Clínica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.
Brain sciences
|August 28, 2025
まとめ
震えの診断は様々な原因により複雑です. AIや神経イメージングなどの 最近の進歩により 精震やパーキンソン症候群の 診断の精度が向上しています
科学分野:
- 神経学
- 運動障害
- 臨床神経科学
背景:
- 震えは流行していますが 診断が難しい運動障害です
- 臨床的異質性と重複する病因は震の診断を複雑にする.
- 2018年のコンセンサスでは,震症候群を2軸の分類で再定義し,エッセンシャル・トレモールプラスのような新しいカテゴリーを導入しました.
研究 の 目的:
- 震の流行学,分類,病理生理学,治療における最近の進歩を統合する.
- 新興の診断と治療のパラダイムに合わせた統合された臨床的枠組みを提供すること.
- 臨床的異質性によって引き起こされる診断上の課題に対処する.
主な方法:
- 震え研究における最近の進歩のレビュー
- 疫学,分類,病理生理学,治療に関する情報の合成
- 特定の震症候群の検査 (本質的震,パーキンソン症候群など) 症候群的,病因的,そして機械的レンズを通して
主要な成果:
- 電気生理学,神経イメージング,ウェアラブルセンサー,人工知能は 震の診断の精度を高めています
- 現在の評価スケールは 限界がありますが 新興のバイオマーカーは有望です
- 様々な震症候群が分析され,診断とメカニズムの洞察が強調されています.
結論:
- 病理生理学的に根拠のある診断基準は 神経調節と精密医療の方向に治療が進化するにつれてますます重要になります
- ネットワークベースのフレームワーク,デジタル診断,個別化された治療戦略を統合することは,震治療の進歩の鍵です.
関連する概念動画
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Disorders of the Nervous Tissue
1.6K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.6K
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445
Disorders of the Autonomic Nervous System
815
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
815


